Medicine and Dentistry

1. Patient 100%
2. Esophageal Adenocarcinoma 95%
3. Positron Emission Tomography-Computed Tomography 83%
4. Neoplasm 72%
5. Neoadjuvant Chemotherapy 61%
6. Therapeutic Procedure 40%
7. Esophageal Cancer 40%
8. Lymph Node 39%
9. Stomach Adenocarcinoma 39%
10. Recurrent Disease 35%
11. Hazard Ratio 34%
12. Glucose 34%
13. Chemotherapy 32%
14. Computer Assisted Tomography 30%
15. Dysplasia 30%
16. Chemotherapy Regimens 30%
17. Medical Research 30%
18. PET-MRI 30%
19. Fluorodeoxyglucose F 18 30%
20. Experience 30%
21. Endoscopic Ultrasound 30%
22. Adenocarcinoma 23%
23. Analysis 19%
24. Esophagectomy 18%
25. Mixed Tumor 17%
26. Primary Tumor 15%
27. Endoscopic Mucosal Resection 15%
28. Proportional Hazards Model 11%
29. Cohort Analysis 11%
30. Esophagus 10%
31. Adverse Event 9%
32. Postoperative Complication 9%
33. Survival Analysis 8%
34. Endoscopic Therapy 7%
35. Disease 7%
36. Histology 7%
37. Tumor Recurrence 7%
38. Stomach Tumor 7%
39. Surgical Margin 7%
40. Fluorine-18 6%
41. Metastatic Carcinoma 6%
42. Neoadjuvant Therapy 6%
43. Hospital 6%
44. Fluorouracil 6%
45. Tumor Regression 5%
46. Prognostic Factor 5%
47. Age 5%
48. Cancer Staging 5%